Effects of disodium etidronate in murine tumor models

A. Guaitani, N. Polentarutti, S. Filippeschi, L. Marmonti, F. Corti, C. Italia, G. Coccioli, M. G. Donelli, A. Mantovani, S. Garattini

Research output: Contribution to journalArticlepeer-review


This study was designed to elucidate the effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) in experimental rodent tumors. EHDP had no antitumor activity against the L1210 leukemia implanted i.p. and against sarcoma 180, Lewis lung carcinoma (3LL) and Walker 256/B carcinoma injected i.p., s.c. or i.m. respectively. EHDP did not interfere with the antitumor activity of commonly used conventional chemotherapeutic agents (adriamycin, cyclophosphamide, 5-fluorouracil, bis-chloroethylnitrosourea) in the L1210 and 3LL models. EHDP reduced proportionally to the dose the hypercalcemia and hypercalciuria due to the Walker 256/B carcinoma growth. In an effort to evaluate whether EHDP-treated osseous tissues were more refractory to tumor growth, cells from sarcoma 180 and 3LL carcinoma were implanted intratibially (i.t.). Growth of 3LL cells was not consistently affected by EHDP, whereas a modest, but significant, growth inhibition was consistently observed with sarcoma 180 injected i.t. Growth of sarcoma 180 implanted i.p. or s.c. was not reduced by this drug, thus suggesting that inhibition of i.t. sarcoma 180 was in fact related to alterations of osseous tissues by EHDP. Inoculation of Walker 256/B carcinoma intra-aortically resulted in osteolytic bone lesions in the hind limbs. EHDP inhibited the formation of bone metastasis under these conditions.

Original languageEnglish
JournalEuropean Journal of Cancer and Clinical Oncology
Issue number5
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Effects of disodium etidronate in murine tumor models'. Together they form a unique fingerprint.

Cite this